Applied Therapeutics, Inc. — Director's Dealing 2022

Sep 17, 2022

SEC Form 4/A — Form 4/A

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2021-04-14

Reporting Person: MARCUS JOEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-14	Common Stock	M	13071	$10.00	Acquired	31524	Indirect
2021-04-14	Common Stock	M	35911	$4.70	Acquired	67435	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-14	Stock Option (Right to Buy)	$10.00	M	13071	Disposed	2029-05-12	Common Stock (13071)	Direct

Footnotes

F1: The original Form 4 filed on April 16, 2021 (the "Original Form 4") incorrectly reported the option exercise price for 13,071 shares of the issuer's common stock as $4.7 due to an administrative error.

F2: This amount reflects the number of securities beneficially owned after the reported transactions on April 14, 2021.

F3: Shares held by family trust, of which the reporting person and his spouse are trustees.

F4: The Original Form 4 incorrectly reported the number of shares acquired from an option exercise as 67,435 due to an administrative error.

F5: The Original Form 4 incorrectly reported the option exercise price for 35,911 shares of the issuer's common stock as $10 due to an administrative error.

F6: 13,071 shares subject to the options were vested as of April 13, 2021, with one thirty-sixth (1/36th) of the remaining shares subject to the options vesting each month thereafter, subject to the reporting person continuing to provide service through each such date.

F7: The Original Form 4 incorrectly reported the number of options beneficially owned following the reported transaction as 7,839 due to an administrative error.